Garg Pushkal bought ALNY
October 1, 2025 · Form 4 insider transaction
Garg Pushkal bought 2,851 shares of Alnylam Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,851
Price
$0.00
Total value
N/A
InsiderGarg Pushkal
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateOctober 1, 2025
Filing dateOctober 3, 2025
Shares owned after26,180
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On March 1, 2024, the reporting person was granted a PSU under the 2018 Stock Incentive Plan. The shares subject to the PSU vest based on the achievement of three specified performance measures. The shares reported were issued to the reporting person upon vesting of thirty (30) percent of the shares subject to the PSU based on the issuer publicly reporting the initiation of a Phase 3 clinical study in a prevalent indication, as determined by the PC&C Committee on October 1, 2025.